CreativeOne Wealth LLC Purchases 447 Shares of Synopsys, Inc. $SNPS

CreativeOne Wealth LLC grew its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 13.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,835 shares of the semiconductor company’s stock after purchasing an additional 447 shares during the quarter. CreativeOne Wealth LLC’s holdings in Synopsys were worth $1,966,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Brighton Jones LLC increased its stake in Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after acquiring an additional 50 shares during the period. Avantax Advisory Services Inc. lifted its holdings in shares of Synopsys by 108.3% during the first quarter. Avantax Advisory Services Inc. now owns 9,083 shares of the semiconductor company’s stock valued at $3,895,000 after acquiring an additional 4,723 shares during the period. Cetera Investment Advisers boosted its position in Synopsys by 21.7% in the first quarter. Cetera Investment Advisers now owns 34,734 shares of the semiconductor company’s stock valued at $14,896,000 after buying an additional 6,186 shares in the last quarter. HB Wealth Management LLC grew its position in Synopsys by 5.2% during the 1st quarter. HB Wealth Management LLC now owns 3,336 shares of the semiconductor company’s stock worth $1,431,000 after acquiring an additional 164 shares during the last quarter. Finally, LPL Financial LLC grew its holdings in shares of Synopsys by 35.9% during the first quarter. LPL Financial LLC now owns 176,628 shares of the semiconductor company’s stock worth $75,350,000 after purchasing an additional 46,661 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Activity at Synopsys

In related news, Director Robert G. Painter acquired 350 shares of the business’s stock in a transaction on Thursday, September 11th. The stock was purchased at an average cost of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the transaction, the director directly owned 2,291 shares of the company’s stock, valued at approximately $974,683.04. The trade was a 18.03% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the sale, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. The trade was a 32.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 30,894 shares of company stock valued at $16,760,783 in the last 90 days. Insiders own 0.62% of the company’s stock.

Synopsys Stock Down 0.7%

Synopsys stock opened at $401.61 on Wednesday. The company’s 50-day moving average is $443.58 and its 200-day moving average is $509.46. The firm has a market capitalization of $74.60 billion, a PE ratio of 31.52, a P/E/G ratio of 5.02 and a beta of 1.10. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same period in the previous year, the business earned $3.43 earnings per share. The business’s quarterly revenue was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on SNPS shares. The Goldman Sachs Group lowered their price target on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. JPMorgan Chase & Co. cut their price target on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 10th. Citigroup started coverage on Synopsys in a report on Monday. They set a “buy” rating and a $580.00 target price on the stock. Stifel Nicolaus cut their price target on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Finally, Baird R W cut Synopsys from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 10th. Ten analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $556.33.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.